A major drug company paying a well-supported 6% dividend can hardly go wrong in the long term.
It's reminiscent of buying ABBV when it was priced to pay a 5% dividend, the dividend now increased by 65% and priced to pay just 3.45%.
Of course the ABBV shares I bought March 24 2020, and still own, when the shares were priced to pay a 7.5% dividend - well that's just dreamy. Paying a 12.4% qualified divi on the initial investment.
It's just a 160% gain, but it was a large initial investment so that's too much profit for us to roll out for now. Perhaps there's a window ten years from now. Other more pressing shares to be sold.
I took our initial NVDA investment off the table this year leaving just the five-fold profit invested. All just psychological bullshit of course, but it leaves me more at peace.
Market Data 
Markets 
AI
